The de-implementation and persistence of low-value HIV prevention interventions in the United States: a cross-sectional study

被引:2
|
作者
Mckay, Virginia R. [1 ]
Combs, Todd B. [1 ]
Dolcini, M. Margaret [2 ]
Brownson, Ross C. [3 ,4 ,5 ]
机构
[1] Washington Univ, Brown Sch, Ctr Publ Hlth Syst Sci, St Louis, MO 63130 USA
[2] Oregon State Univ, Coll Publ Hlth & Human Sci, Hallie E Ford Ctr Hlth Children & Families, Corvallis, OR USA
[3] Washington Univ, Prevent Res Ctr, Brown Sch, St Louis, MO USA
[4] Washington Univ, Dept Surg, Div Publ Hlth Sci, Sch Med, Washington Univ St Louis, St Louis, MO USA
[5] Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO USA
来源
关键词
De-implementation; HIV prevention; Public health; Evidence-based intervention; BEHAVIORAL INTERVENTIONS; CAPACITY; ADOPTION;
D O I
10.1186/s43058-020-00040-6
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background As more effective or efficient interventions emerge out of scientific advancement to address a particular public health issue, it may be appropriate to de-implement low-value interventions, or interventions that are less effective or efficient. Furthermore, factors that contribute to appropriate de-implementation are not well identified. We examined the extent to which low-value interventions were de-implemented among public health organizations providing HIV prevention services, as well as explored socio-economic, organizational, and intervention characteristics associated with de-implementation.Methods We conducted an online cross-sectional survey from the fall of 2017 to the spring of 2019 with organizations (N = 188) providing HIV prevention services in the USA. Organizations were recruited from the Center for Disease Control and Prevention's (CDC) website gettested.org from 20 metropolitan statistical areas with the highest HIV incidence. An organization was eligible to participate if the organization had provided at least one of the HIV prevention interventions identified as inefficient by the CDC in the last ten years, and one administrator familiar with HIV prevention programming at the organization was recruited to respond. Complete responses were analyzed to describe intervention de-implementation and identify organizational and intervention characteristics associated with de-implementation using logistic regression.Results Organizations reported 359 instances of implementing low-value interventions. Out of the low-value interventions implemented, approximately 57% were group, 34% were individual, and 5% were community interventions. Of interventions implemented, 46% had been de-implemented. Although we examined a number of intervention and organizational factors thought to be associated with de-implementation, the only factor statistically associated with de-implementation was organization size, with larger organizations-those with 50+ FTEs-being 3.1 times more likely to de-implement than smaller organizations (95% CI 1.3-7.5).Conclusions While low-value interventions are frequently de-implemented among HIV prevention organizations, many persisted representing substantial inefficiency in HIV prevention service delivery. Further exploration is needed to understand why organizations may opt to continue low-value interventions and the factors that lead to de-implementation.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Overuse and Misuse of Inhaled Corticosteroids Among Veterans with COPD: a Cross-sectional Study Evaluating Targets for De-implementation
    Griffith, Matthew F.
    Feemster, Laura C.
    Zeliadt, Steven B.
    Donovan, Lucas M.
    Spece, Laura J.
    Udris, Edmunds M.
    Au, David H.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (03) : 679 - 686
  • [42] Reducing low-value care: what can we learn from eight de-implementation studies in the Netherlands?
    Verkerk, Eva W.
    van Dulmen, Simone A.
    Westert, Gert P.
    Hooft, Lotty
    Heus, Pauline
    Kool, Rudolf B.
    BMJ OPEN QUALITY, 2022, 11 (03)
  • [43] 'Low-value' clinical care in general practice: a cross-sectional analysis of low-value care in early-career GPs' practice
    Ralston, Anna
    Fielding, Alison
    Holliday, Elizabeth
    Ball, Jean
    Tapley, Amanda
    van Driel, Mieke
    Davey, Andrew
    Turner, Rachel
    Moad, Dominica
    FitzGerald, Kristen
    Spike, Neil
    Mitchell, Ben
    Tran, Michael
    Fisher, Katie
    Magin, Parker
    INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 2023,
  • [44] De-imFAR phase II project: a study protocol for a cluster randomised implementation trial to evaluate the effectiveness of de-implementation strategies to reduce low-value statin prescribing in the primary prevention of cardiovascular disease
    Sanchez, Alvaro
    Pijoan, Jose Ignacio
    de Rozas, Rita Sainz
    Lekue, Itxasne
    San Vicente, Ricardo
    Quindimil, Jose Antonio
    Rotaeche, Rafael
    Etxeberria, Arritxu
    Mozo, Carmela
    Martinez-Cengotitabengoa, Monica
    Monge, Monica
    Gomez-Ramirez, Cristina
    Samper, Ricardo
    Lana, Mikel Ogueta
    Celorrio, Sara
    Merino-Inda, Nerea
    Llarena, Marta
    de Tejada, Marta Gonzalez Saenz
    Garcia-Alvarez, Arturo
    Grandes, Gonzalo
    BMJ OPEN, 2024, 14 (04):
  • [45] A Tailored De-Implementation Strategy to Reduce Low-Value Home-Based Nursing Care: A Mixed-Methods Feasibility Study
    Wendt, Benjamin
    Nieuwboer, Minke S.
    Vermeulen, Hester
    Huisman-de Waal, Getty
    van Dulmen, Simone A.
    JOURNAL OF ADVANCED NURSING, 2024,
  • [46] Applying the behavior change wheel to design de-implementation strategies to reduce low-value statin prescription in primary prevention of cardiovascular disease in primary care
    Sanchez, Alvaro
    Elizondo-Alzola, Usue
    Pijoan, Jose, I
    Mediavilla, Marta M.
    Pablo, Susana
    de Rozas, Rita Sainz
    Lekue, Itxasne
    Gonzalez-Larragan, Susana
    Llarena, Marta
    Larranaga, Olatz
    Helfrich, Christian D.
    Grandes, Gonzalo
    FRONTIERS IN MEDICINE, 2022, 9
  • [47] Effects of de-implementation strategies aimed at reducing low-value nursing procedures: a systematic review and meta-analysis
    Tessa Rietbergen
    Denise Spoon
    Anja H. Brunsveld-Reinders
    Jan W. Schoones
    Anita Huis
    Maud Heinen
    Anke Persoon
    Monique van Dijk
    Hester Vermeulen
    Erwin Ista
    Leti van Bodegom-Vos
    Implementation Science, 15
  • [48] Vigilance for HIV/AIDS: a cross-sectional study of 2 million adults in the United States
    Rethemiotaki, Irene
    HIV & AIDS REVIEW, 2021, 20 (02): : 96 - 101
  • [49] Understanding the multilevel determinants of clinicians’ imaging decision-making: setting the stage for de-implementation of low-value imaging
    Soohyun Hwang
    Sarah A. Birken
    Matthew E. Nielsen
    Jennifer Elston-Lafata
    Stephanie B. Wheeler
    Lisa P. Spees
    BMC Health Services Research, 22
  • [50] Unpacking low-value castration practices using behavior specification to guide de-implementation in prostate cancer care.
    Skolarus, Ted A.
    Forman, Jane
    Sparks, Jordan B.
    Metreger, Tabitha
    Hawley, Sarah T.
    Caram, Megan Veresh
    Dossett, Lesly Ann
    Larkin, Angela
    Cruz, Alan Paniagua
    Makarov, Danil V.
    Leppert, John T.
    Shelton, Jeremy B.
    Stensland, Kristian D.
    Hollenbeck, Brent K.
    Shahinian, Vahakn
    Wittmann, Daniela A.
    Deolankar, Varad
    Sriram, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17055 - E17055